0 Members and 1 Guest are viewing this topic.
June 3 (UPI) -- Stem cell therapy using cells produced from a patient's own bone marrow may reduce reliance on insulin or other medications for Type 2 diabetes treatment, according to a study published Thursday in the journal Stem Cells Translational Medicine.A clinical trial conducted at Vinmec Research Institute of Stem Cell and Gene Technology in Hanoi found that stem cell treatment allowed some patients to reduce or eliminate their need for other medications for at least some period of time, researchers said...."The procedure is safe and opens the way for other clinical trials exploring the potential benefits of this treatment in non-obese patients who have had the disorder less than 10 years," co-study lead author Liem Nguyen, research director at Vinmec, said in a press release.Researchers added, however, that the benefit was found only in those who were not overweight and have not had the disease for more than a decade -- the benefit was only measured on a short term basis.
